Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05143554

Auricular Neurostimulation for Chemotherapy Induced Nausea and Vomiting

Conditions: Chemotherapy-induced Nausea and Vomiting

Sex: All
Ages: 4 Years – 30 Years
Healthy volunteers: No
Phase: NA
Enrollment: 18
Sponsor: Medical College of Wisconsin

Location: Children's Wisconsin Hospital Milwaukee Wisconsin

Summary

This study evaluates the efficacy of auricular percutaneous electrical nerve field stimulator in children, adolescents and young adults with chemotherapy induced nausea and vomiting.

Eligibility Criteria

Inclusion Criteria: * Subjects who are scheduled to be admitted for chemotherapy administration and who will have at least one additional cycle of the same chemotherapy * Chemotherapy regimens must include moderate and/or severe emetogenic chemotherapy Exclusion Criteria: * Significant developmental delays that would prohibit participation * Infection or severe dermatological condition of ear * Uncontrolled or severe infection * No implanted electrical device is permitted * Pregnancy * Severe cardiopulmonary disease * Diagnosis of hemophilia or other bleeding disorders * Diagnosis psoriasis vulgaris

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05143554). StuddyBuddy aggregates publicly available trial information.